Dr Alison Marshall

Lecturer

MA, PhD

Medicine & Health

The Kirby Institute

Alison is a Postdoctoral Fellow co-appointed at the Viral Hepatitis Clinical Research Program (the Kirby Institute) and the Centre for Social Research in Health at UNSW Sydney. In 2018, Alison received her PhD in clinical epidemiology at the Kirby Institute. Her PhD research utilised a mixed-methods approach (quantitative-qualitative design) with a primary focus on liver disease assessment, hepatitis C treatment uptake, and health policy. Prior to her PhD, Alison’s work involved multidisciplinary collaborations with international (WHO, PAHO) and national public health agencies (PHAC, CDC) to facilitate the uptake of evidence-based research in the development of hepatitis C policy, programs, and practices in global health settings.

Alison is also a current Fellow of the Canadian Institutes for Health Research (CIHR) funded program, the Canadian Network on Hepatitis C (CanHepC). Her most recent research is directed at remaining barriers to hepatitis C care in the interferon-free era for people who inject drugs.

Phone

+61 (2) 9385 9960

E-mail

amarshall@kirby.unsw.edu.au

Journal articles | 2024

Marshall AD; Conway A; Cunningham EB; Valerio H; Silk D; Alavi M; Tillakeratne S; Wade A; Lam T; Zohrab K; Dunlop A; Connelly C; Cock V; Burns C; Henderson C; Christmass M; Dore GJ; Grebely J, 2024, 'A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage Study', Viruses, 16,

Journal articles | 2024

Marshall AD; Rance J; Dore GJ; Grebely J; Treloar C, 2024, 'Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study', International Journal of Drug Policy, 129,

Journal articles | 2024

Valerio H; Alavi M; Marshall AD; Hajarizadeh B; Amin J; Law M; Tillakeratne S; George J; Degenhardt L; Grebely J; Matthews GV; Dore GJ, 2024, 'Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population-based study', Drug and Alcohol Review, 43, pp. 1080 - 1092,

Journal articles | 2024

Valerio H; Marshall AD; Conway A; Treloar C; Carter L; Martinello M; Henderson C; Amin J; Read P; Silk D; Degenhardt L; Prain B; Alavi M; Dore GJ; Grebely J, 2024, 'Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study', International Journal of Drug Policy, 127,

Journal articles | 2023

Cheng Q; Bajis S; Cunningham E; Shih STF; Schulz M; Marshall AD; Martin NK; Miners A; Hajarizadeh B; Wiseman V; Dore GJ; Grebely J, 2023, 'Health-related quality of life among people who inject drugs in Australia', Quality of Life Research, 32, pp. 3195 - 3207,

Journal articles | 2023

Clay S; Treloar C; Degenhardt L; Grebely J; Christmass M; Gough C; Hayllar J; McDonough M; Henderson C; Crawford S; Farrell M; Marshall A, 2023, '‘I just thought that was the best thing for me to do at this point’: Exploring patient experiences with depot buprenorphine and their motivations to discontinue', International Journal of Drug Policy, 115,

Journal articles | 2023

Clay S; Wilkinson Z; Ginley M; Arunogiri S; Christmass M; Membrey D; MacCartney P; Sutherland R; Colledge-Frisby S; Marshall AD; Nagle J; Degenhardt L; Farrell M; McKetin R, 2023, 'Perspectives and sentiments on contingency management from people who use methamphetamine', Drug and Alcohol Review, 42, pp. 1427 - 1437,

Journal articles | 2023

Conway A; Krawczyk N; McGaffey F; Doyle S; Baaklini V; Marshall AD; Treloar C; Davis CS; Colledge-Frisby S; Grebely J; Cerdá M, 2023, 'Typology of laws restricting access to methadone treatment in the United States: A latent class analysis', International Journal of Drug Policy, 119,

Journal articles | 2023

Conway A; Marshall AD; Crawford S; Hayllar J; Grebely J; Treloar C, 2023, 'Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study', Implementation Science, 18,

Journal articles | 2023

Conway A; Treloar C; Crawford S; Degenhardt L; Dore GJ; Farrell M; Hayllar J; Grebely J; Marshall AD, 2023, '“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic', International Journal of Drug Policy, 114,

Journal articles | 2023

Conway A; Treloar C; Crawford S; Grebely J; Marshall AD, 2023, 'People engaged in opioid agonist treatment as a counterpublic during the COVID-19 pandemic in Australia: A qualitative study', Drug and Alcohol Review, 42, pp. 203 - 212,

Journal articles | 2023

Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Bajis S; Valencia BM; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J, 2023, 'Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis', International Journal of Drug Policy, 111,

Journal articles | 2023

Lafferty L; Schroeder S; Marshall AD; Drysdale K; Higgs P; Stoové M; Baldry E; Dietze P; Treloar C, 2023, 'Trust and service engagement among people who inject drugs after release from prison', International Journal of Drug Policy, 111,

Journal articles | 2023

Marshall AD; Martinello M; Zolopa C; Treloar C; Larney S, 2023, 'Universal hepatitis C virus screening and treatment as part of prenatal care', The Lancet Gastroenterology and Hepatology, 8, pp. 295 - 297,

Journal articles | 2023

Marshall AD; Schroeder SE; Lafferty L; Drysdale K; Baldry E; Stoové M; Dietze P; Higgs P; Treloar C, 2023, 'Perceived access to opioid agonist treatment in prison among people with a history of injection drug use: A qualitative study', Journal of Substance Use and Addiction Treatment, 150,

Journal articles | 2023

Snell G; Marshall AD; van Gennip J; Bonn M; Butler-Mcphee J; Cooper CL; Kronfli N; Williams S; Bruneau J; Feld JJ; Janjua NZ; Klein M; Cunningham N; Grebely J; Bartlett SR, 2023, 'Public reimbursement policies in Canada for direct-acting antiviral treatment of hepatitis C virus infection: A descriptive study', Canadian Liver Journal, 6, pp. 190 - 200,

Journal articles | 2022

Conway A; Valerio H; Alavi M; Silk D; Treloar C; Hajarizadeh B; Marshall AD; Martinello M; Milat A; Dunlop A; Murray C; Prain B; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Christmass M; Wade A; Montebello M; Dore GJ; Grebely J, 2022, 'A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study', Viruses, 14,

Journal articles | 2022

Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Valencia BM; Bajis S; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J, 2022, 'Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis', The Lancet Gastroenterology and Hepatology, 7, pp. 426 - 445,

Journal articles | 2022

Horwitz R; Brener L; Marshall AD; Caruana T; Newman CE, 2022, 'Optimising community health services in Australia for populations affected by stigmatised infections: What do service users want?', Health and Social Care in the Community, 30, pp. e3686 - e3695,

Journal articles | 2022

Larney S; Madden A; Marshall AD; Martin NK; Treloar C, 2022, 'A gender lens is needed in hepatitis C elimination research', International Journal of Drug Policy, 103,

Journal articles | 2022

Marshall AD; Conway A; Cunningham EB; Valerio H; Silk D; Alavi M; Wade A; Lam T; Zohrab K; Dunlop A; Connelly C; Christmass M; Cock V; Burns C; Henderson C; Wiseman V; Dore GJ; Grebely J, 2022, 'Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatment', Drug and Alcohol Dependence, 235,

Journal articles | 2022

Marshall AD; Martinello M; Treloar C; Matthews GV, 2022, 'Perceptions of hepatitis C treatment and reinfection risk among HIV-positive men who have sex with men and engage in high risk behaviours for hepatitis C transmission: The CEASE qualitative study', International Journal of Drug Policy, 109,

Journal articles | 2022

Marshall AD; Matthews GV, 2022, 'Simplifying hepatitis C care models: a crucial step towards hepatitis C elimination', The Lancet Gastroenterology and Hepatology, 7, pp. 1066 - 1068,

Journal articles | 2022

Marshall AD; Rance J; Grebely J; Treloar C, 2022, '‘Not just one box that you tick off’ – Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective', International Journal of Drug Policy, 102,

Journal articles | 2022

Schroeder SE; Drysdale K; Lafferty L; Baldry E; Marshall AD; Higgs P; Dietze P; Stoove M; Treloar C, 2022, '"It's a revolving door": Ego-depletion among prisoners with injecting drug use histories as a barrier to post-release success', International Journal of Drug Policy, 101, pp. 103571,

Journal articles | 2021

Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J, 2021, 'Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study', International Journal of Drug Policy, 96,

Journal articles | 2021

Grebely J; Collins AB; Artenie AA; Sutherland R; Meyer JP; Barocas JA; Falade-Nwulia O; Cepeda JA; Cunningham EB; Hajarizadeh B; Lafferty L; Lazarus JV; Bonn M; Marshall AD; Treloar C, 2021, 'Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs', International Journal of Drug Policy, 96,

Journal articles | 2021

Treloar C; Schroeder S; Lafferty L; Marshall A; Drysdale K; Higgs P; Baldry E; Stoove M; Dietze P, 2021, 'Structural competency in the post-prison period for people who inject drugs: A qualitative case study', International Journal of Drug Policy, 95, pp. 103261,

Journal articles | 2020

Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ; Peolim L; How-Chow D; Telenta J; Harvey P; Jones S; Dunlop A; Treloar C; Samuel Y; Poeder F; Crawford S; Baxter A; Keats J; Mowat Y; Silk D; Micallef M; Tamaddoni M; Marks P; Lamoury F; Jayasinghe I; Reid H; Cunningham EB; Bartlett S; Jacka B; Erratt A; Jauncey M; Collie P; Lam T; Gilliver R; Hazelwood S; Houlihan N; Burns C; Lewis R; Morris D; Donohue K; Carthew A; Horasak N; Cherry R; Shin S; Peterson D; Sellwood T; McKeown W; Pritchard-Jones J; Smyth F; Adey S; Clark K; Grebely J; Applegate T; Read P; Hajarizadeh B; Ezard N; Dore G; Edwards M, 2020, 'Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study', Journal of Viral Hepatitis, 27, pp. 281 - 293,

Journal articles | 2020

Marshall AD; Grebely J; Dore GJ; Treloar C, 2020, 'Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience', Drug and Alcohol Dependence, 206,

Journal articles | 2020

Marshall AD; Hopwood M; Grebely J; Treloar C, 2020, 'Applying a diffusion of innovations framework to the scale-up of direct-acting antiviral therapies for hepatitis C virus infection: Identified challenges for widespread implementation', International Journal of Drug Policy, 86,

Journal articles | 2019

Marshall AD; Madden A; Treloar C, 2019, 'Enhancing engagement in hepatitis C care among people who inject drugs', Addiction, 114, pp. 2104 - 2106,

Journal articles | 2018

Bajis S; Maher L; Treloar C; Hajarizadeh B; Lamoury FMJ; Mowat Y; Schulz M; Marshall AD; Cunningham EB; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Whelan M; Martinello M; Applegate TL; Dore GJ; Grebely J, 2018, 'Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia', International Journal of Drug Policy, 61, pp. 23 - 30,

Journal articles | 2018

Cheng ML; Abdel-Hakeem MS; Cousineau SE; Grebely J; Marshall AD; Saeed S; Sagan SM; Shoukry NH; Feld JJ; Macparland SA, 2018, 'The 7th canadian symposium on hepatitis c virus: “toward elimination of hcv: How to get there”', Canadian Liver Journal, 1, pp. 139 - 152,

Journal articles | 2018

Lamoury FMJ; Bajis S; Hajarizadeh B; Marshall AD; Martinello M; Ivanova E; Catlett B; Mowat Y; Marks P; Amin J; Smith J; Ezard N; Cock V; Hayllar J; Persing DH; Kleman M; Cunningham P; Dore GJ; Applegate TL; Grebely J, 2018, 'Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay', Journal of Infectious Diseases, 217, pp. 1889 - 1896,

Journal articles | 2018

Marshall AD; Cunningham EB; Nielsen S; Aghemo A; Alho H; Backmund M; Bruggmann P; Dalgard O; Seguin-Devaux C; Flisiak R; Foster GR; Gheorghe L; Goldberg D; Goulis I; Hickman M; Hoffmann P; Jancorienė L; Jarcuska P; Kåberg M; Kostrikis LG; Makara M; Maimets M; Marinho RT; Matičič M; Norris S; Ólafsson S; Øvrehus A; Pawlotsky JM; Pocock J; Robaeys G; Roncero C; Simonova M; Sperl J; Tait M; Tolmane I; Tomaselli S; van der Valk M; Vince A; Dore GJ; Lazarus JV; Grebely J, 2018, 'Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe', The Lancet Gastroenterology and Hepatology, 3, pp. 125 - 133,

Journal articles | 2018

Marshall AD; Pawlotsky JM; Lazarus JV; Aghemo A; Dore GJ; Grebely J, 2018, 'The removal of DAA restrictions in Europe – One step closer to eliminating HCV as a major public health threat', Journal of Hepatology, 69, pp. 1188 - 1196,

Journal articles | 2018

Marshall AD; Treloar C; Dore GJ; Grebely J, 2018, 'A239 QUALITATIVE EVALUATION OF THE DECISIONS AND EXPERIENCES OF PEOPLE WHO INJECT DRUGS WHO RECEIVED A LIVER DISEASE ASSESSMENT AS PART OF A LIVER HEALTH PROMOTION CAMPAIGN: THE LIVERLIFE STUDY', Journal of the Canadian Association of Gastroenterology, 1, pp. 419 - 419,

Journal articles | 2018

Neale J; Tompkins CNE; Marshall AD; Treloar C; Strang J, 2018, 'Building on feminist achievements to enhance choice for women seeking treatment', Addiction, 113, pp. 1001 - 1002,

Journal articles | 2018

Neale J; Tompkins CNE; Marshall AD; Treloar C; Strang J, 2018, 'Do women with complex alcohol and other drug use histories want women-only residential treatment?', Addiction, 113, pp. 989 - 997,

Journal articles | 2017

Bajis S; Lamoury F; Applegate TL; Maher L; Treloar C; Mowat Y; Schulz M; Hajarizadeh B; Marshall A; Cunningham E; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Dore GJ; Grebely J, 2017, 'P4 Acceptability of point of care finger-stick and venepuncture hepatitis C virus testing among people who inject drugs and homeless people', Journal of Virus Eradication, 3, pp. 13 - 14,

Journal articles | 2017

Grebely J; Lamoury FMJ; Hajarizadeh B; Mowat Y; Marshall AD; Bajis S; Marks P; Amin J; Smith J; Edwards M; Gorton C; Ezard N; Persing D; Kleman M; Cunningham P; Catlett B; Dore GJ; Applegate TL, 2017, 'Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study', The Lancet Gastroenterology and Hepatology, 2, pp. 514 - 520,

Journal articles | 2017

Marshall AD; Grebely J; Dore GJ; Treloar C, 2017, '‘I didn't want to let it go too far.’ The decisions and experiences of people who inject drugs who received a liver disease assessment as part of a liver health promotion campaign: The LiveRLife study', International Journal of Drug Policy, 47, pp. 153 - 160,

Journal articles | 2017

McPhail S; Schippers M; Marshall A, 2017, 'Development and Testing a Physical Activity Intervention for Ambulatory Older Patients During Rehabilitation', Archives of Physical Medicine and Rehabilitation, 98, pp. e21 - e22,

Journal articles | 2016

Marshall AD; Saeed S; Barrett L; Cooper CL; Treloar C; Bruneau J; Feld JJ; Gallagher L; Klein MB; Krajden M; Shoukry NH; Taylor LE; Grebely J; Canadian Network on Hepatitis C (CanHepC) , 2016, 'Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study.', CMAJ Open, 4, pp. E605 - E614,

Journal articles | 2016

Van Buuren N; Fradette L; Grebely J; King A; Krajden M; Macparland SA; Marshall A; Saeed S; Wilson J; Klein MB; Sagan SM, 2016, 'The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet - Remaining Challenges in Hepatitis C', Canadian Journal of Gastroenterology and Hepatology, 2016, pp. 7603526,

Journal articles | 2015

Marshall AD; Micallef M; Erratt A; Telenta J; Treloar C; Everingham H; Jones SC; Bath N; How-Chow D; Byrne J; Harvey P; Dunlop A; Jauncey M; Read P; Collie T; Dore GJ; Grebely J, 2015, 'Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study', International Journal of Drug Policy, 26, pp. 984 - 991,

Journal articles | 2012

Eakin E; Reeves M; Dunstan D; Healy G; Winkler E; Marshall A; Owen N, 2012, 'Living well with Diabetes: Six-month randomised trial outcomes of a telephone-delivered weight loss intervention', Journal of Science and Medicine in Sport, 15, pp. S202 - S202,

Journal articles | 2011

Brosseau L; Wells GA; Tugwell P; Egan M; Dubouloz CJ; Casimiro L; Bugnariu N; Welch VA; De Angelis G; Francoeur L; Milne S; Loew L; Mcewan J; Messier SP; Doucet E; Kenny GP; Prud'homme D; Lineker S; Bell M; Poitras S; Li JX; Finestone HM; Laferrière L; Haines-Wangda A; Russell-Doreleyers M; Lambert K; Marshall AD; Cartizzone M; Teav A, 2011, 'Ottawa Panel evidence-based linical practice guidelines for the anagement of osteoarthritis in dults who are obese or overweight', Physical Therapy, 91, pp. 843 - 861,

Journal articles | 2008

Brosseau L; Wells GA; Tugwell P; Egan M; Wilson KG; Dubouloz CJ; Casimiro L; Robinson VA; McGowan J; Busch A; Poitras S; Moldofsky H; Harth M; Finestone HM; Nielson W; Haines-Wangda A; Russell-Doreleyers M; Lambert K; Marshall AD; Veilleux L, 2008, 'Ottawa panel evidence-based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: Part 1', Physical Therapy, 88, pp. 857 - 871,

Journal articles | 2008

Brosseau L; Wells GA; Tugwell P; Egan M; Wilson KG; Dubouloz CJ; Casimiro L; Robinson VA; McGowan J; Busch A; Poitras S; Moldofsky H; Harth M; Finestone HM; Nielson W; Haines-Wangda A; Russell-Doreleyers M; Lambert K; Marshall AD; Veilleux L, 2008, 'Ottawa panel evidence-based clinical practice guidelines for strengthening exercises in the management of fibromyalgia: Part 2', Physical Therapy, 88, pp. 873 - 886,
Conference Papers | 2022

Clay S; Treloar C; Degenhardt L; Grebely J; Farrell M; Marshall AD, 2022, 'Options: Exploring patients' experiences with depot buprenorphine and their motivations to discontinue', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S43 - S43,

Conference Abstracts | 2022

Treloar C; Broady T; Drysdale K; Brener L; Schroeder SE; Lafferty L; Marshall AD; Dietze PM; Higgs P; Stoove M; Baldry E, 2022, 'Changing attitudes of the general public towards people with prison and injecting drug use histories: A research-informed, co-designed, arts-based intervention', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S136 - S137,

Conference Papers | 2021

Conway A; Treloar C; Crawford S; Degenhardt L; Dore GJ; Farrell M; Grebely J; Marshall AD, 2021, '"WE'VE HAD A CIRCUIT BREAKER FOR AN OLD DOGMA OF MORE THAN 20 YEARS": CHANGES TO OPIOID AGONIST TREATMENT SERVICES DURING COVID-19, THE CHOICE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S59 - S59,

Conference Papers | 2021

Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Amin J; Christmass M; Dunlop AJ; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Dore GJ; Treloar C; Grebely J, 2021, 'OPIOID OVERDOSE AND NALOXONE ACCESS AMONG PEOPLE WHO RECENTLY USED OPIOIDS OR RECEIVED OPIOID AGONIST TREATMENT IN AUSTRALIA: THE ETHOS ENGAGE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S59 - S60,

Conference Papers | 2021

Marshall AD; Crawford S, 2021, 'MINI SYMPOSIUM: INTERVENTIONS TO IMPROVE ACCESS TO HEPATITIS C TESTING AND TREATMENT FOR PEOPLE WHO USE DRUGS', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S28 - S28,

Reports | 2020

Brener L; Horwitz R; Marshall A; Newman C, 2020, Impact of stigma and discrimination experienced by priority populations affected by STIs and BBVs in the ACT, Centre for Social Research in Health, UNSW Sydney, Sydney

Conference Abstracts | 2019

Hajarizadeh B; Marshall AD; Grebely J; Dore GJ; Treloar C; Corry A; Hayllar J; Byrne J, 2019, 'SYMPOSIUM: ENHANCING HEPATITIS C CARE AMONG PEOPLE WHO INJECT DRUGS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S8 - S9,

Conference Papers | 2019

Marshall AD; Grebely J; Dore GJ; Treloar C, 2019, 'BARRIERS AND FACILITATORS TO ENGAGING IN HEPATITIS C MANAGEMENT AND DIRECT-ACTING ANTIVIRAL THERAPY AMONG GENERAL PRACTITIONERS AND DRUG AND ALCOHOL SPECIALISTS: THE PRACTITIONER EXPERIENCE', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S9 - S9,

Conference Abstracts | 2019

Neale J; Tompkins CNE; Marshall AD; Treloar C; Strang J, 2019, 'DO WOMEN WITH COMPLEX ALCOHOL AND OTHER DRUG USE HISTORIES WANT WOMEN-ONLY RESIDENTIAL TREATMENT?', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S76 - S76,

Conference Papers | 2018

Lamoury F; Bajis S; Hajarizadeh B; Marshall A; Martinello M; Ivanova E; Catlett B; Mowat Y; Marks P; Amin J; Smith J; Ezard N; Cock V; Hayllar J; Persing D; Kleman M; Cunningham P; Dore G; Applegate T; Grebely J, 2018, 'Evaluation of the Xpert fingerstick HCV viral load assay', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S167 - S167, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018,

Other | 2018

Lancaster K; Marshall A; Dertadian G; Yates K; Rance J, 2018, Qualitative Methods Journal Club July 2018 - ‘Sending the Wrong Signal’, Society for the Study of Addiction, ,

Other | 2018

Lancaster K; Marshall A; Dertadian G; Yates K; Rance J, 2018, Qualitative Methods Journal Club June 2018 - Conceiving of addicted pleasures, Society for the Study of Addiction, ,

Other | 2018

Lancaster K; Marshall A; dertadian G; yates K; Rance J, 2018, Qualitative Methods Journal Club May 2018 - Why am I the way I am?, Society for the Study of Addiction, ,

Other | 2018

Marshall A; Lancaster K; Dertadian G; Yates K; Rance J, 2018, Qualitative Methods Journal Club April 2018 - Sleeping at the Margins, ,

Other | 2018

Marshall A; Lancaster K; Dertadian G; Yates K; Rance J, 2018, Qualitative Methods Journal Club February 2018 - Parents Who Use Drugs, Society for the Study of Addiction, ,

Other | 2018

marshall A; Lancaster K; Dertadian G; Yates K; Rance J, 2018, Qualitative Methods Journal Club March 2018 - Ethnography and Injecting Drug Use, Society for the Study of Addiction, ,

Conference Papers | 2017

Grebely J; Lamoury F; Hajarizadeh B; Mowat Y; Marshall A; Bajis S; Marks P; Amin J; Smith J; Edwards M; Gorton C; Ezard N; Persing D; Kleman M; Cunningham P; Catlett B; Dore G; Applegate TL, 2017, 'Field evaluation of Xpert (R) HCV Viral Load point-of-care test for detection of hepatitis C virus infection by venipuncture-collected and finger-stick capillary whole-blood samples', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S709 - S709, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017,

Conference Abstracts | 2017

Marshall AD; Nielsen S; Cunningham EB; Aghemo A; Alho H; Backmund M; Bruggmann P; Dalgard O; Flisiak R; Foster G; Gheorghe L; Goldberg D; Goulis I; Hickman M; Hoffmann P; Jancoriene L; Jarcuska P; Kaberg M; Makara M; Maimets M; Marinho R; Maticic M; Norris S; Olafsson S; Ovrehus A; Pawlotsky J-M; Pocock J; Robaeys G; Roncero C; Simonova M; Sperl J; Tait M; Tolmane I; Tomaselli S; van der Valk M; Vince A; Dore GJ; Lazarus JV; Grebely J, 2017, 'Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, Vol. 66, pp. S95 - S96, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017,

Conference Abstracts | 2016

Grebely J; Marshall AD; Krahe M; Erratt A; Telenta J; Treloar C; Jones SC; Adey S; Bath N; How-Chow D; Byrne J; Harvey P; Dunlop AJ; Applegate TL; Lamoury F; Mowat Y; Jauncey M; Read P; Gilliver R; Smith J; Collie T; Dore GJ, 2016, 'A LIVER HEALTH PROMOTION INTERVENTION INTEGRATING NON-INVASIVE LIVER DISEASE SCREENING IN DRUG AND ALCOHOL SETTINGS: THE LIVERLIFE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 40 - 40

91���˰涶��

Follow

Dr Alison Marshall

91��˰涶��